JENNISON ASSOCIATES LLC – BioMarin Pharmaceutical Inc. Transaction History
JENNISON ASSOCIATES LLC portfolio value:
$47.76M
portfolio value
JENNISON ASSOCIATES LLC quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -22.72% | -165.66K shares | -12.65M | $84.77 | 563.50K |
Q2 2022 | share | Increase | +3.20% | 22.64K shares | 5.95M | $82.87 | 729.17K |
Q1 2022 | share | Increase | +27.87% | 153.98K shares | 5.65M | $77.1 | 706.52K |
Q4 2021 | share | Increase | 0.00% | 552.54K shares | 48.81M | $89.08 | 552.54K |
Q1 2021 | call | Decrease | -100.00% | -50K shares | -4.38M | $75.51 | 0 |
Q1 2021 | share | Decrease | -100.00% | -453.99K shares | -39.81M | $75.51 | 0 |
Q4 2020 | share | Decrease | -30.45% | -198.79K shares | -9.85M | $87.69 | 453.99K |
Q4 2020 | call | Increase | 0.00% | 50K shares | 4.38M | $87.69 | 50K |
Q3 2020 | share | Decrease | -91.40% | -6.93M shares | -886.58M | $76.08 | 652.79K |
Q2 2020 | share | Decrease | -7.59% | -623.69K shares | 242.12M | $123.34 | 7.59M |
Q1 2020 | share | Increase | +16.68% | 1.17M shares | 98.87M | $84.5 | 8.21M |
Q1 2020 | call | Decrease | -100.00% | -60K shares | -5.07M | $84.5 | 0 |
Q4 2019 | call | Increase | 0.00% | 60K shares | 5.07M | $84.55 | 60K |
Q4 2019 | share | Decrease | -15.50% | -1.29M shares | 33.71M | $84.55 | 7.04M |
Q3 2019 | share | Decrease | -11.82% | -1.11M shares | -247.66M | $67.4 | 8.33M |
Q2 2019 | share | Decrease | -23.89% | -2.96M shares | -293.40M | $85.65 | 9.44M |
Q1 2019 | share | Increase | +7.00% | 812.13K shares | 114.83M | $88.83 | 12.41M |
Q4 2018 | share | Increase | +6.97% | 756.22K shares | -63.78M | $85.15 | 11.60M |
Q3 2018 | share | Decrease | -6.42% | -744.39K shares | -40.08M | $96.97 | 10.84M |
Q2 2018 | share | Decrease | -1.48% | -174.19K shares | 138.03M | $94.2 | 11.58M |
Q1 2018 | share | Decrease | -0.40% | -46.87K shares | -99.45M | $81.07 | 11.76M |
Q4 2017 | share | Decrease | -4.10% | -504.66K shares | -93.02M | $89.17 | 11.80M |
Q3 2017 | share | Decrease | -7.01% | -928.41K shares | -56.61M | $93.07 | 12.31M |
Q2 2017 | share | Increase | +33.84% | 3.34M shares | 334.16M | $90.82 | 13.24M |
Q1 2017 | share | Increase | +6.81% | 631.14K shares | 101.16M | $87.78 | 9.89M |
Q4 2016 | share | Decrease | -4.52% | -438.74K shares | -130.26M | $82.84 | 9.26M |
Q3 2016 | share | Increase | +7.19% | 650.95K shares | 193.46M | $92.52 | 9.70M |
Q2 2016 | share | Increase | +3.44% | 301.35K shares | -17.50M | $77.8 | 9.05M |
Q1 2016 | put | Decrease | -100.00% | -230K shares | -24.09M | $82.48 | 0 |
Q1 2016 | share | Increase | +30.76% | 2.05M shares | 20.70M | $82.48 | 8.74M |